Unbiased AI-powered news
Isaac Argro, 26, received a sentence of 25 years to life in prison Tuesday for the shooting death of Azsia Johnson. The killing occurred on the Upper East Side while Johnson pushed their infant daughter in a stroller.
New York PostIsaac Argro, 26, was sentenced Tuesday to 25 years to life in prison for the murder of Azsia Johnson, 20. Manhattan Supreme Court Justice Gregory Carro imposed the term after a jury convicted Argro of murder in fewer than two hours. The shooting took place in June 2022 on East 95th Street between Lexington and Third Avenues.
Argro wore a black ski mask and shot Johnson point-blank in the head as she pushed their infant daughter Khloe in a stroller, according to court records. He fled the scene and later threatened Johnson’s family, prosecutors said. During the sentencing hearing Argro addressed the court.
“I know what I’m about to say doesn’t really mean anything to anybody, but I just wanted to say that I’m sorry for whatever I did or whatnot,” he said. ” Lisa Desort, Johnson’s mother, wept as she spoke to the judge. “It’s been the worst four years of our life,” she said.
Desort told the court that her grandchildren Khloe and Kenzo are now orphans in foster care. “Khloe and Kenzo’s lives will never be the same again because of Mr. Argro,” she said. ” Justice Carro described the killing as a “senseless domestic violence killing” motivated by control rather than the child.
“It had do with a ‘I can’t have you, no one can have you,’” he said. Manhattan District Attorney Alvin Bragg hugged Desort outside the courtroom.
Single source — no framing comparison available.
A 26-year-old Colombian national was fatally shot in Biddeford on Monday. The incident prompted federal officials to suspend most vehicle stops nationwide after two recent deaths.
Retired pilot Chesley Sullenberger said on July 14, 2026, that he has early-stage Alzheimer’s disease. He described initial symptoms and expressed resolve to face the condition with his family.
Japan TimesThe University of Oxford has started an early-stage clinical trial of a vaccine targeting the Bundibugyo strain of Ebola. The trial will enroll 50 healthy adults to test safety and immune response.